These specialized units can help keep older patients out of the hospital, lower their health care costs and more.

The voluntary recall included eggs produced in Texas and sold under several brand names in six states, the Food and Drug Administration said.

The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.

Companies in Africa and India will make generic versions of the pill that could cost as little as $5 per person per year. But access to the drug and other new products in much of Latin America remains uncertain.

In a recent study, scientists devised a way of reversing the buildup of compounds that lead to some age-related diseases.

The agency is considering whether compounding pharmacies should be allowed to produce BPC-157, TB-500 and other previously banned peptides.

The Agency for Healthcare Research and Quality slowed the awarding of new grants last year. Now it is stopping existing ones.

Senator Bill Cassidy, who is believed to hold the deciding vote in the Senate health committee for Dr. Erica Schwartz’s confirmation, had declined for days to say whether he would back her.

Agency scientists are advising against allowing widespread use of several peptide injections. Robert F. Kennedy Jr., the health secretary, has said people should be free to experiment.

For the first time, officials have acknowledged problems with the No Surprises Act, which has led to huge payments.

The administration canceled federal grants to organizations across the country, accusing them of encouraging premarital sex. New criteria say programs should stress abstinence.